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Background: Electronic cigarettes (e-cigarettes) have risen in popularity in the U.S. While recent studies have
described the prevalence and demographics of e-cigarette users, few studies have evaluated the impact of advertising
on perceptions and interest in trial. This pilot study was conducted to assess whether exposure to ads for e-cigarettes
or a comparison product (snus), elicited differences in interest to try e-cigarettes between smokers and non-smokers.
Methods: A web-based survey was completed by 600 respondents, aged 18–65, recruited from an internet panel in
the U.S. Respondents answered questions assessing tobacco use, and then viewed nine magazine ads for Blu
e-cigarettes or Camel snus, a low-nitrosamine smokeless tobacco product, in random order. After viewing each
ad, respondents were asked a series of questions about their perceptions, beliefs, attitudes, and interest in trial. At the
end, respondents were asked to choose a free sample product from the following options: an e-cigarette, smokeless
tobacco (SLT), pack of cigarettes, or no product.
Results: Ad receptivity scores did not appear to be influenced by ad theme; differences existed between smokers and
non-smokers. Participants exposed to e-cigarette ads more frequently reported favorable product attitudes compared
to participants exposed to snus ads. Cigarette smokers in the e-cigarette condition were more likely to report interest
in trying e-cigarettes compared to non-smokers in that condition (p-value < 0.001). Six percent of non-smokers exposed
to e-cigarette ads reported interest in trying e-cigarettes. E-cigarettes were the most popular product selected to sample
(34 %), followed by cigarettes (8 %) and SLT (3 %); 331 respondents (55 %) chose no product. Participants randomized to
the e-cigarette ad group were significantly more likely to choose an e-cigarette at product selection (p-value = 0.014).
Within the e-cigarette condition, 71 % of smokers selected an e-cigarette at product selection, compared to 25 %
of non-smokers; smoking status was significantly associated with sample product selection (p-value <0.001).
Conclusions: These findings suggest that exposure to e-cigarette ads may be associated with interest in e-cigarette
trial, particularly among smokers. Continued exposure to advertising in magazines, on television, and at the
point-of-sale may have an impact on willingness to receive promotional products or intention to try e-cigarettes.
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E-cigarettes are a novel phenomenon. These devices pro-
vide nicotine to users in the form of an aerosol vapor,
which is promoted as a reduced risk form of delivery.
Awareness of e-cigarettes and other electronic nicotine
delivery devices is increasing. Recent nationally represen-
tative studies conducted among the U.S. adult general
population have shown that awareness of e-cigarettes has
risen from approximately 40 % in 2010, to nearly 60 % in
2011 [1, 2]. A survey conducted from 2010–2011 among
current and former U.S. cigarette smokers reported that
73 % of responders were aware of e-cigarettes, denoting a
heighted awareness of these products among this popula-
tion subgroup [3].
The increased awareness of e-cigarettes may be linked
to a corresponding increase in media presence; including
ads in magazines, television, and strategic product place-
ment of e-cigarettes in Hollywood productions. For
example, e-cigarettes have been used by celebrities in
commercials, print ads, movies, and television shows [4].
Availability of e-cigarettes is also increasing in a variety of
retail outlets, including gas stations, convenience stores,
mall kiosks, vapor lounges, and over the Internet [5–7]. In
addition to independent e-cigarette manufacturers, the
tobacco industry has also expanded their product line
to include e-cigarettes (e.g., RJ Reynolds’ production of
Vuse, Altria’s production of MarkTen). Using strategies
similar to those they have successfully employed in the
past to market and distribute conventional cigarettes,
Lorillard was the first to market Blu e-cigarettes on TV
[8]. These ads showed celebrities using e-cigarettes in
places where smoking is banned by clean indoor air
legislation. Manufacturer investments in advertising
and marketing for e-cigarettes are increasing. Recent
reports have found that advertising and marketing of
e-cigarettes by e-cigarette manufacturers across all
media channels exceeded $82 million in 2013 and con-
tinues to increase [9–11]. With increased awareness
resulting from increased exposure, Lorillard expanded
the distribution of Blu electronic cigarettes to over
50,000 retailers by the fourth quarter of 2012, result-
ing in net sales for this time period totaling approxi-
mately $39 million [12].
While e-cigarettes may be beneficial for individual
smokers as a harm reduction device, it is yet unclear if
these devices yield a positive or negative public health
impact. The use of e-cigarettes as a complete replace-
ment for conventional cigarettes or as a quit aid could
result in a net public health gain [13, 14]. However,
use of e-cigarettes in conjunction with cigarettes or
other tobacco products, or introduction of nicotine to
non-smokers would have an overall negative impact
on public health. For example, a recent study con-
ducted among a sample of U.S. adults demonstratedthat current daily and non-daily smokers are more
likely to concurrently use e-cigarettes than those who
had never smoked cigarettes, suggesting potential for
dual-use in lieu of complete substitution. The authors
of this study also found that nearly one-third of current
e-cigarette users are non-smokers, including both former
and never users of conventional cigarettes [15].
Evidence from multiple U.S. Surgeon General’s reports
support the notion that tobacco advertising and promo-
tion can influence risk perception, trial, and use of to-
bacco products in both adults and youth [16–18]. Such
evidence contributed to the establishment of regulations
to limit tobacco advertising and marketing in the United
States [19–21]. Current restrictions on tobacco advertising
in the U.S. include a bans on outdoor marketing (includ-
ing billboards and public transit), advertising that targets
youth (including use of cartoons), sponsorship of sporting
or other public events, and ads on television and radio.
Although e-cigarettes are planned for regulation as a
‘tobacco product’ by the Center for Tobacco Products
in the U.S. Food and Drug Administration (FDA), cur-
rently, e-cigarette products are not subject to the same
promotional restrictions as cigarettes. (For example,
e-cigarettes advertisements are currently aired on tele-
vision.) [22] As of November 2014, at least 40 state
level authorities have banned the sale of e-cigarettes to
minors, and over 200 jurisdictions have amended their
clean indoor air legislation to include the prohibition of
e-cigarettes in places where traditional cigarette smok-
ing is not allowed. [23–25] Forthcoming restrictions on
e-cigarettes in the U.S. could include restrictions on
advertising [22].
While an increasing number of recently published studies
have described awareness and use of e-cigarettes [1–3],
very few studies have evaluated associations between
advertising and e-cigarette perceptions and interest in
trial. Such studies have largely focused among the im-
pact of advertising and trial among smokers [26], but
we are not aware of studies that have expanded this
concept to include non-smokers. With the increasing
number of tobacco companies expanding their product
lines to include e-cigarettes, as well as the increasing
number of independent e-cigarette manufacturers in
the market, there is concern that increased advertising,
coupled with the sharp increase in availability, may in-
fluence current tobacco users and non-users (including
never and former users) to consider trial and adoption
of e-cigarettes.
This pilot study aimed to explore issues related to
e-cigarette advertising and the potential impact such ad-
vertisements may have on the public’s willingness to try
e-cigarettes among current smokers and non-smokers.
Namely, we sought to assess whether exposure to ads
for e-cigarettes or a comparison product (snus), showed
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cigarette smokers and non-smokers.
Methods
Study procedures
This web-based survey was conducted in March 2013
among cigarette smokers and non-smokers, including
current users of e-cigarettes (see schema, Fig. 1). Sample
members were recruited through a web panel managed
by Global Market Insite, an organization specializing in the
administration of online surveys (http://www.lightspeedgmi.
com/). Eligible participants answered a series of preliminaryFig. 1 Study designquestions to confirm that they were between ages 18
and 65, current United States residents, and able to read
and write in English. After determining eligibility, par-
ticipants were directed to an informed consent screen,
clicking a button indicating consent. Respondents com-
pleted a core series of questions adapted from a similar
study assessing tobacco use, past quit attempts, use of
nicotine replacement therapies, and knowledge, attitudes,
and beliefs about nicotine-containing products [27]. Next,
respondents were randomized to one of two exposure
groups to view magazine ads for (Blu) e-cigarettes or
(Camel) snus. Advertisements belonged to one of three a
Smith et al. Tobacco Induced Diseases  (2015) 13:14 Page 4 of 12priori themes discerned by raters prior to survey initiation
(as described below). Once a participant was randomized
to a condition, they were shown nine ads for that product.
Within-product presentation sequence of ads was ran-
domized to minimize ordering effects. Participants were
asked a series of questions after viewing each ad, as well
as a shortened list of product attitudes used in prior
research (Table 1) [28–30]. After viewing all ads in their
assigned group, participants were asked, “If we had the
opportunity to send you a free sample of one of the
products listed below, which of the products would you
choose?” (response options: an e-cigarette, a tin of smoke-
less tobacco, a pack of cigarettes, or ‘please do not send
me any of these’). At this point, participants were not ex-
plicitly made aware by the research team that they would
not receive a free sample product. Following the selection
of a product, participants were debriefed and informed
that ethical guidelines do not allow the researchers to mail
free samples of products. The research protocol was ap-
proved by the Institutional Review Board at Roswell Park
Cancer Institute in Buffalo, NY.Product advertisements
For this study, Camel snus ads were selected as compari-
son ads because prior research has indicated that message
themes and presentation in print advertising for snus are
similar to those for e-cigarettes [31, 32]. Three trained
coders who were unaffiliated with the study independently
coded each ad on a series of thematic characteristics
(Fleiss’s Kappa = 0.55; pa [proportion of agreements to
total ratings] = 0.71). Selected themes on which the ads
were rated include: 1) less dangerous to health than ciga-
rettes; 2) product use in non-smoking situations; and 3)
stylish alternative to tobacco cigarettes. All advertisementsTable 1 Ad measures
Perceptions about Ads Product attitudes
This ad… Based on what I just saw, I think
this product…
…was clear …is sophisticated
…had a message that was
important to me
…is fun
…made me stop and think …is satisfying
…made me curious to know if that
the ad says is true
…is stupid
…is one I would talk to other
people about
…is hard to quit using
…told me something new …makes me nauseated
…talked down to me …is for kids
…said things that were hard
to believe
…is for adults
…is something I want to trywere found on the website, “Trinkets & Trash: Artifacts of
the Tobacco Epidemic” (www.trinketsandtrash.org) [33].




Variables indicating product use were computed for all
tobacco products asked about within the questionnaire
(cigarettes, smokeless tobacco or SLT, and e-cigarettes).
“Current users” for a tobacco product were defined as
those individuals who responded “Yes” to the question,
“Have you ever used [tobacco product- cigarettes, SLT,
electronic cigarettes], even once?” and currently reported
using the tobacco product every day or some days. “Ever
users” for a tobacco product were defined as those indi-
viduals who responded “Yes” to the question, “Have you
ever used [tobacco product], even once?”, and currently
reported not using the product at all. “Never users” for a
tobacco product were defined as those individuals who
responded “No” to the question, “Have you ever used
[tobacco product], even once?” In analyses examining
differences between current cigarette smokers versus
current non-smokers, “ever” and “never” smokers were
combined into one category.
Ad receptivity
For each individual ad, we asked the series of statements
shown in Table 1 (response options: strongly agree, agree,
neither agree nor disagree, disagree, strongly disagree). To
indicate favorable perceptions toward each ad, we created
a summary score from selected measures: (This ad…was
important to me, made me stop and think, made me curi-
ous to know if what the ad says is true, is one I would talk
to other people about, told me something new; Cronbach’s
alpha = 0.98). These measures were chosen as a result of
the high internal consistency for responses to the items.
For each measure, responses were scored from 0 (strongly
disagree) to 5 (strongly agree), then summed together.
The scores for each measure were then added to create
the summary score for the individual ad. The summary
scores for individual ads were then grouped by each of the
three ad themes (less dangerous to health than cigarettes;
circumvent clean indoor air restrictions; stylish alternative
to tobacco cigarettes) and totaled to create an “ad receptiv-
ity score” for that set of ads (range: 0–75). We also created
a combined ad receptivity score to examine differences for
the entire condition, regardless of ad theme (range: 0–225).
Main outcome measures
We employed two different measures to assess interest
in trying e-cigarettes within our sample. The first measure,
“intention to try”, was based on the statement: “Based on
what I just saw, I think this product is something I want
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agree nor disagree, disagree, strongly disagree). To keep
our analysis succinct, we opted to recode this Likert mea-
sure into a binary variable. The answer options “strongly
agree” and “agree” were combined to indicate “intention
to try”, while the remaining options were combined to
indicate “does not intend to try”.
The second measure, labeled “willingness to receive a
free product”, was derived from the question adminis-
tered for product selection by respondents, which stated,
“If we had the opportunity to send you a free sample of
one of the products listed below, which of the products
would you choose?” (response options: an e-cigarette, a
tin of smokeless tobacco, a pack of cigarettes, or ‘please
do not send me any of these’).
Statistical analysis
Descriptive analyses were performed on these pilot data.
Pearson chi-square tests were conducted to assess associa-
tions between demographic variables, smoking status and
main outcome measures (all categorical). Demographic
measures included age group (18–24, 25–34, 35–44,
45–54, 55–65), gender (male vs. female), level of edu-
cation (high school graduate or less, some college, and
bachelor’s degree or higher), and racial self-identification
(white non-Hispanic, black non-Hispanic, Hispanic, other
race non-Hispanic). Independent samples t-tests (equal
variance assumed) were used in comparing mean ad re-
ceptivity scores, grouped according to cigarette smo-
king status (current smoker versus current non-
smoker) Cramer’s V is reported for effect sizes related to
Pearson chi-square tests, while Cohen’s d is reported for
effect sizes related to independent samples t-tests. Results
are reported for four groups of interest: Smokers who
viewed ads for e-cigarettes, non-smokers who viewed ads
for e-cigarettes, smokers who viewed ads for snus, and
non-smokers who viewed ads for snus.
Results
A total of 46,561 e-mail invitations were sent to GMI
panelists, inviting them to take part in the survey. 875
individuals began the survey, of which 600 completed
the survey in full (Table 2). Most participants were aged
55–65 (23 %), had some college education (47 %), and
identified as being white, non-Hispanic (80 %); the sam-
ple had similar proportions of males and females. Rela-
tive to national estimates, there were a high proportion
of current smokers (31 %), and current SLT users (8 %)
in our sample [34]. Among cigarette smokers, prevalence
of current e-cigarette use was 21 %, while among current
non-smokers only 1 % used e-cigarettes (χ2 = 144.692,
p-value < 0.001; Cramer’s V = .491). Current smokeless
tobacco use among current cigarette smokers was 17 %,
while 4 % of current non-smokers reported use ofsmokeless tobacco (χ2 = 32.338, p-value < 0.001, Cramer’s
V = .232). Ten percent of the total sample reported using
more than one tobacco product, while nearly 20 % of
our sample consisted of individuals who have at least
tried an e-cigarette one time (12 % ever users, 7 %
current users).
Product attitudes
Participants were asked to respond to a set of questions
assessing attitudes about the product shown in their ex-
posure condition (e-cigarette or snus) displayed in Table 1.
In general, participants in our study who were exposed to
e-cigarette ads rated their product more favorably across
this set of measures when compared to participants who
were shown ads for snus (Table 3). As one between-
condition example, 36 % of participants who viewed
e-cigarette ads agreed that the product was “sophisti-
cated”, compared to 14 % of participants who reported the
same for snus; we observed a positive, moderately strong
relationship between product attitudes and ad exposure
grouping. (χ2 = 46.237, p-value < 0.001, Cramer’s V = .278).
Table 4 outlines within-condition comparisons of product
attitudes according to participant smoking status. Among
participants that viewed ads for e-cigarettes, smokers
more frequently reported favorable attitudes toward
e-cigarettes compared to non-smokers. As one within-
condition example for e-cigarettes, 57 % of current
smokers reported that e-cigarettes were “sophisticated”
compared to 27 % of non-smokers who reported the same.
We observed a positive, strong relationship between
product attitudes and smoking status (χ2 = 31.117,
p-value < 0.001, Cramer’s V = .322). Similar trends were
observed among smokers and non-smokers within the
snus comparison condition. Among all non-smokers in
either condition, more favorable perceptions were
observed for e-cigarettes compared to snus.
Ad receptivity
Figure 2 displays ad receptivity scores stratified by expo-
sure condition and smoking status. Within the e-cigarette
condition, the combined mean ad receptivity score for
smokers was 138.63 (SD = 39.09). By contrast, the com-
bined mean ad receptivity score for non-smokers who
viewed e-cigarette ads was 98.52 (SD = 44.01); we observed
a positive, strong relationship between e-cigarette ad recep-
tivity and smoking status (t(298) = 7.525, p-value < 0.001,
Cohen’s d = 0.872). In the snus comparison condition, the
combined mean ad receptivity score for smokers was
113.41 (SD = 45.10), compared to 98.92 (SD = 45.25) for
non-smokers. We observed a positive, weak relation-
ship between snus ad receptivity and smoking status
(t(298) = 2.561, p-value = .011, Cohen’s d = 0.297). Mean
ad receptivity scores among smokers in the snus condi-
tion ranged from 37.51-38.30, while mean ad receptivity
Table 2 Participant demographic characteristics stratified by advertisement viewing conditiona (n = 600)
SNUS advertisements (n = 300) E-cigarette advertisements (n = 300) Total sample
n % n % p-value %
Gender Male 144 48 152 51 0.514 49
Female 156 52 148 49 51
Age 18-24 61 20 45 15 0.405 18
25-34 49 16 60 20 18
35-44 61 20 57 19 20
45-54 61 20 67 22 21
55-65 68 23 71 24 23
Education HS Grad/GED or less 55 18 55 18 0.852 18
Some college 139 46 144 48 47
Bachelors + 106 35 99 33 34
Race White 231 77 244 82 0.405 80
Black 22 7 19 6 7
Hispanic 29 10 19 6 8
Other 18 6 15 5 5
Cigarette use Never Smoker 96 32 77 26 0.168 29
Ever Smoker 112 37 131 44 41
Current Smoker 92 31 92 31 31
SLT use Never User 233 78 232 77 0.909 78
Ever User 43 14 46 15 15
Current User 24 8 22 7 8
E-cigarette use Never User 172 57 165 55 0.7 56
Ever User 38 13 36 12 12
Current User 17 6 24 8 7
Unaware of EC 73 24 75 25 25
Dual/Polyuse No Tobacco 201 67 198 66 0.367 67
Single Product 74 25 72 24 24
Cigs and SLT 9 3 7 2 3
Cigs and E-cigs 7 2 16 5 4
SLT and E-cigs 0 0 1 0 0
Polyuser (Cigs + SLT + EC) 9 3 6 2 3
P-value denotes significance resulting from chi-square test of independence between advertisement exposure groups
aThe percentages presented for the total sample may not equal 100 % due to rounding





χ2 p-value Cramer’s V
…is sophisticated 14 36 46.24 <.001 0.278
…is fun 15 29 23.73 <.001 0.199
…is satisfying 20 38 34.59 <.001 0.240
…is stupid 48 36 30.12 <.001 0.224
…is hard to quit using 53 31 48.15 <.001 0.284
…makes me nauseated 39 19 49.91 <.001 0.288
…is for kids 8 3 6.06 0.417 0.100
…is for adults 51 73 39.17 <.001 0.256
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χ2 p-value Cramer’s V
…is sophisticated 22 11 23.79 <.001 0.282 57 27 31.12 <.001 0.322
…is fun 23 12 32.24 <.001 0.328 50 20 41.36 <.001 0.371
…is satisfying 35 13 33.00 <.001 0.332 63 27 46.49 <.001 0.394
…is stupid 31 56 29.14 <.001 0.312 19 43 38.96 <.001 0.360
…is hard to quit using 43 57 19.24 0.004 0.253 22 35 17.07 0.004 0.239
…makes me nauseated 29 43 10.39 0.109 0.186 4 26 37.46 <.001 0.353
…is for kids 11 6 6.21 0.4 0.144 7 3 10.56 0.103 0.188
…is for adults 60 47 20.51 0.002 0.261 88 67 22.10 0.001 0.271
Fig. 2 Ad receptivity scores across themes, stratified by ad exposure and smoking status (n = 600). Significant differences in mean ad receptivity
scores were observed between current smokers and non-smokers within each ad condition (Independent samples t-test, p-value<0.05). Error bars
denote 95 % confidence interval for estimate
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from 45.68-47.09.
Exposure to advertisements and intention to try
In the combined sample, 94 respondents (16 %) reported
that the product shown in their exposure grouping (snus
or e-cigarettes) was “something I want to try” (Fig. 3)
Among all participants who were shown ads for
e-cigarettes, 21 % expressed interest in trying e-cigarettes.
Cigarette smokers in the e-cigarette condition were more
likely to report interest in trying e-cigarettes compared to
non-smokers in that condition (χ2 = 91.95, p-value < 0.001,
Cramer’s V = .554). Among all participants in the snus
comparison condition, 10 % reported that they intended to
try snus and a weaker, yet statistically significant associ-
ation was observed between smoking status and intention
to use snus (χ2 = 13.49, p-value < 0.001, Cramer’s V = .212).
Exposure to advertisements and willingness to receive a
free sample product
In the product selection task, over half of the sample
(55 %) elected to not be sent a free sample product.
E-cigarettes were the most frequently selected tobacco
product among all participants, with 34 % reporting this
choice. Selection of smokeless tobacco and cigarettes
among sample members was low (3 % and 8 %, respect-
ively). Participants exposed to e-cigarettes ads were
more likely to select an e-cigarette as their hypothetical
free product (39 %) compared to participants who saw
ads for snus (28 %). In comparing ad exposure condi-
tions, we observed a statistically significant association
between ad exposure grouping and product choice (χ2 =
10.59, p-value = 0.014, Cramer’s V = .133). Within theFig. 3 Percentage of respondents reporting intention to try product shown
were observed between current smokers and non-smokers within each ade-cigarette condition, smokers more frequently selected
an e-cigarette at product selection, compared to non-
smokers (Fig. 4). We observed a strong statistically signifi-
cant association between smoking status and product
choice within this exposure grouping (χ2 = 91.78, p-value <
0.001, Cramer’s V = .553). Within the snus condition,
e-cigarettes remained the most frequently selected tobacco
product among responders, with smokers more frequently
reporting this choice than non-smokers. Product choice in
the snus condition was significantly associated with smok-
ing status (χ2 = 121.92, p-value < 0.001, Cramer’s V = .637).
Comparing intention to try and willingness to receive a
free sample product
In total, 16 % of respondents reported that they intended
to try the product shown in their exposure condition.
Forty-five percent of respondents elected to receive a
sample product (e-cigarette, smokeless tobacco, or a pack
of cigarettes). Among smokers in the e-cigarette condition
who reported intending to try an e-cigarette, 90 %
selected the e-cigarette as their sample product, while
10 % selected another option. Among smokers in the
e-cigarette condition who did not report intending to try
an e-cigarette, 46 % selected the e-cigarette as their sample
product, while 53 % selected another option (χ2 = 25.53,
p-value < 0.001, Cramer’s V = .527). One-quarter of non-
smokers in the e-cigarette condition selected the e-cigarette
as their sample product; 3 % of which previously reported
intention to try the product after being shown ads for
e-cigarettes. These findings among non-smokers in the
e-cigarette condition were not statistically significant.
In the snus comparison condition, we did not observe
any significant associations between product selectionin exposure condition (n = 600). Significant differences in responses
condition (Pearson chi-square test, p-value<0.05)
Fig. 4 Associations between smoking status and willingness to receive a product, stratified by exposure condition (n = 600). Product selection
within each exposure group was significantly associated with smoking status, according to chi-square test of independence (p<0.001)
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non-smokers in the snus condition, 5 % of non-smokers
previously reported intention to try snus, while 4 %
selected smokeless tobacco during product selection.
Nearly 16 % of non-smokers in the snus condition
chose an e-cigarette during product selection. We ob-
served a statistically significant association between
product choice and intention to try snus among non-
smokers in the snus condition (χ2 = 9.25, p-value = .026,
Cramer’s V = .211).
Discussion
This pilot study is among the first to test associations
between intention to try e-cigarettes and exposure to
e-cigarette advertising in a sample of both smokers
and non-smokers. The findings from this pilot study
suggest that exposure to advertising for e-cigarettes
may enhance interest in e-cigarette trial, particularly
among cigarette smokers.
In this study, participants who were exposed to
e-cigarette advertising were twice as likely to have
reported an intention to use e-cigarettes in the future,
consistently rated their product more favorably than those
exposed to snus ads, and more frequently selected
e-cigarettes as their product of choice when offered a
free sample product. This could be a result of e-cigarette
ad exposure in general, as ads provide a mechanism to
communicate awareness of this product. Yet, in our
product selection task, participants exposed to snus also
more frequently selected e-cigarettes as their chosen
sample product, albeit not as frequently as those exposed
to e-cigarette ads. We conclude that this could simply
indicate a general preference toward e-cigarettes relative
to snus, given that e-cigarettes are a relatively novel
product. There may be aspects of e-cigarettes (in terms
of construction, utility, or other factors) that mayenhance appeal as a product that may reduce harm to
health. Such aspects are not currently addressed by the
data presented in this report, and should be studied in
greater detail.
These data suggest that more favorable perceptions
toward e-cigarettes existed among all participants, but
particularly among current cigarette smokers, who rated
e-cigarette ads, interest in trial, and attitudinal measures
on e-cigarettes more favorably when compared to snus,
a similarly marketed harm reduction product. Smokers
exposed to either form of advertising overwhelmingly
chose the e-cigarette in the product selection task, yet
this was much more frequently observed among
smokers in the e-cigarette condition. This product
selection occurred over other options, one of which was
a pack of cigarettes. Such findings may suggest that
e-cigarettes, often proposed as a product that may reduce
harm to health, appear to be more favorable to smokers
than snus, another frequently proposed harm reduction
product. These pilot data do not measure specifically why
this may be the case. Snus is a smokeless tobacco product,
possessing a different mode of administration for nicotine
than e-cigarettes, and smokeless products currently carry
health warning labels as mandated by law. Our findings also
support the notion of snus posing relatively low appeal to
smokers for harm reduction, as demonstrated through
previous studies [27, 35]. Factors that may attract
smokers to certain tobacco products should be examined
more closely through future research.
While we observed more favorable ad receptivity
scores for e-cigarette ads compared to snus among
smokers, ad receptivity for either tobacco product was
relatively similar among non-smokers in both condi-
tions. Additionally, non-smokers in our study generally
did not report intention to use either of the products
they were exposed to, with 6 % of non-smokers in each
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ing ads. In the product selection task, non-smokers
were more likely to reject the offer of a free sample
tobacco product, compared to smokers. Interestingly, a
small proportion of non-smokers who did not previ-
ously report intention to try e-cigarettes prior to the
offer of a free e-cigarette opted to select a free sample
e-cigarette. The broader implications of these findings
among non-smokers are unclear. With the limited
offering of products during product selection, coupled
with the absence of measures to indicate reasons for se-
lection of a particular product or participant follow-up
over time, we cannot be sure whether non-smokers in
our sample chose a free tobacco product for personal
use or for some other reason. Future studies should
examine such reasons in greater detail.
Our data did not allude to particular advertisement
themes (e.g., using e-cigarettes in non-smoking situa-
tions) having a strong association with either use
intention to use or willingness to receive a free prod-
uct. It could be that other elements of advertisements
not addressed in this study could play a determining
factor in influencing interest in these products, a few
of which have been demonstrated in other studies. For
example, Pepper et al. [26] conducted a study in 2013
among a sample of smokers who have never tried e-
cigarettes. The group found that ads emphasizing differ-
ences between conventional cigarettes and e-cigarettes,
along with ads that showed a person using an e-cigarette,
were more likely to generate interest in trying e-cigarettes
among smokers than ads that did not possess those
features. Future research should examine what, if any other
characteristics of ads for e-cigarettes may influence use
intention, actual product use, and under what circum-
stances these products may be used.
There are potential negative and positive public health
impacts of widespread promotion and advertising of
e-cigarettes. If e-cigarettes are deemed by the FDA as a po-
tentially reduced exposure product or a smoking-cessation
aid, then advertising targeted to smokers to switch to these
products completely for harm reduction or cessation could
be beneficial for overall public health. The data for this
study showed that smokers were interested in receiving
a free sample e-cigarette, regardless of advertising condi-
tion; the data also showed that 3 % of non-smokers in
the e-cigarette condition displayed interest in trying
e-cigarettes. Yet, when offered a free sample tobacco
product, 25 % of non-smokers in the e-cigarette condi-
tion selected an e-cigarette. The current marketing
environment for e-cigarettes is saturated with promotions
and price discounts for these products. Such an environ-
ment could result in a greater proportion of non-tobacco
users to consider trying e-cigarettes. While our data do not
directly speak to increased uptake among non-tobaccousers, our findings suggest low interest, and more extensive
research is needed to determine the appeal of e-cigarettes
to nonusers of tobacco.Limitations
The findings from our pilot study are subject to limita-
tions. Primarily, this study was conducted among a fairly
small sample recruited from an opt-in panel of internet
users. When compared to the U.S. general population,
our sample members more frequently reported having a
college degree (34 % sample, 29 % population), were
more likely to identify as being White, non-Hispanic
(80 % sample, 64 % population), and had higher rates of
cigarette (31 % sample, 18 % population) and smokeless
tobacco use (8 % sample, 3 % population) [34, 36]. This
affects our ability to generalize our findings to the
broader population, and future research should explore
this issue among a larger and more broadly generalizable
sample. Yet, this sampling method also allowed us to
capture more tobacco users, which is important given our
findings among cigarette smokers. The sample size also
limited our ability to examine these data in greater detail
using multivariate modeling. An additional limitation was
the use of existing advertisements for one brand of each
product (Blu e-cigarettes, Camel snus). This was a result
of the minimal market presence of e-cigarette advertising
for other brands at the time this pilot was conducted. We
cannot account for influences in intention to try that may
vary based on brand loyalty, perceptions of a specific
branded product, or prior exposure to the ads shown in
this pilot study. As e-cigarette advertising becomes
more commonplace, future studies should examine use
intentions among other e-cigarette brands or other
novel tobacco products. This pilot was also limited to a
sample of U.S. adults aged 18 to 65. Additional research
is needed to explore the impact of e-cigarette advertising
and trial among a sample of youth to better inform future
directions on e-cigarettes. Additionally, our study did not
include baseline measures assessing attitudes about
e-cigarettes or snus prior to the ads being shown to
participants. Such baseline measures would have utility
in better isolating effects related to product advertising
or product novelty. Future studies should assess
attitudes about e-cigarettes at baseline in order to
better disentangle advertising effects from product atti-
tudes. Finally, we evaluated only one form of advertising
among several that exist for these types of products. How-
ever, repeated exposure to marketing through other
channels and modalities may have a greater impact on
perceptions, so our estimates may be lower than what
may be the case for additive effects of other advertising
exposures. Despite these limitations, these data are
among the first we are aware of that show associations
Smith et al. Tobacco Induced Diseases  (2015) 13:14 Page 11 of 12between e-cigarette advertising and interest in trial
among both smokers and non-smokers.
Conclusions
Continued promotion and advertising may peak public
interest in e-cigarettes compared to snus, and may have
an impact on willingness to receive promotional pro-
ducts or intention to try e-cigarettes. Our study found
that e-cigarette advertising may influence intention to
try these products, particularly among current smokers.
In addition to the absence of an established safety profile
and regulation on the quality of e-cigarettes, additional
considerations about product advertising should be
considered in developing future regulatory actions.
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